What is the protocol for administering lidocaine (local anesthetic) injection for a medical procedure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Lidocaine injection should be administered with caution, using the lowest effective dose, and with careful monitoring for signs of toxicity, as recommended by the most recent guidelines 1. When administering lidocaine injection for a medical procedure, it is essential to follow proper protocols to minimize the risk of local anesthetic systemic toxicity.

  • The maximum safe dose of lidocaine is 4.5 mg/kg without epinephrine or 7 mg/kg with epinephrine, as stated in the guidelines 1.
  • Aspirating the needle before injection is crucial to avoid introducing the drug directly into a vessel, as recommended by the guidelines 1.
  • Incremental injections of anesthetic and continual assessment of the patient for signs of early toxicity are also vital, as emphasized in the guidelines 1.
  • The use of intravenous lidocaine for acute pain should be ratified and approved by the local hospital and medication governance committee, or equivalent, and patients should be informed of the possible benefits and risks, as stated in the consensus statement 1.
  • Ideal body weight should be used for dose calculation, and intravenous lidocaine should not be used in patients weighing < 40 kg, as recommended by the consensus statement 1.
  • A loading dose of no more than 1.5 mg.kg-1, given as an infusion over 10 min, is recommended, followed by an infusion of no more than 1.5 mg.kg-1.h-1, for no longer than 24 h, as stated in the consensus statement 1.
  • Patients receiving intravenous lidocaine should be managed in a monitored bedspace in a high dependency unit (level 2 care), with particular vigilance in patients with existing comorbidity, as recommended by the consensus statement 1.
  • Lipid emulsion 20% should be readily available wherever intravenous lidocaine is used, and staff should know where it is kept, in case of toxicity, as emphasized in the consensus statement 1.

From the FDA Drug Label

Lidocaine HCl Injections are indicated for production of local anesthesia by infiltration techniques such as percutaneous injection by peripheral nerve block techniques such as brachial plexus and intercostal, when the accepted procedures for these techniques as described in standard textbooks are observed. The protocol for administering lidocaine injection is by:

  • Infiltration techniques: such as percutaneous injection
  • Peripheral nerve block techniques: such as brachial plexus and intercostal It is essential to follow the accepted procedures as described in standard textbooks for these techniques 2.

From the Research

Protocol for Administering Lidocaine Injection

The protocol for administering lidocaine injection for a medical procedure involves several key considerations, including:

  • Using a small needle (27- to 30-gauge) to deliver anesthesia to the entry sites 3
  • Delivering anesthetic along the advancement pathway of the device and marked targets using a 20-gauge spinal needle 3
  • Administering a limited volume of dilute lidocaine anesthesia, with a mean delivered anesthesia volume of 357.2 ml (range, 250-525 ml) or 18.7 mg/kg (range, 11.1-28.4 mg/kg) 3
  • Monitoring for adverse events and signs of toxicity, with no signs of toxicity reported in study patients 3

Key Considerations

Some key considerations when administering lidocaine injection include:

  • The use of lidocaine alone as an excellent anesthetic for most patients, with the option to use less painful injectable agents, topical anesthetics, and oral sedation for frightened or pain-intolerant patients 4
  • The comparison of lidocaine with other local anesthetics, such as bupivacaine, which has a prolonged duration of anesthesia 5, 6
  • The use of lidocaine in various routes of administration, including neuraxial, perineural, intravenous, infiltrative approaches, topical, and transdermal 7

Administration Techniques

Different administration techniques have been studied, including:

  • Limited dilute lidocaine infiltration, which facilitates a comfortable procedure and rapid recovery process 3
  • Mixing solutions, such as a 50/50 mixture of lidocaine and bupivacaine, which has been shown to have no significant difference in onset and duration of anesthesia compared to using the solutions independently 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Choosing a local anesthetic.

Dermatologic clinics, 1994

Research

Local anesthetics. Is there an advantage to mixing solutions?

Journal of the American Podiatric Medical Association, 1996

Research

A clinical comparison of lidocaine and bupivacaine.

Annals of emergency medicine, 1987

Research

New local anesthetics.

Best practice & research. Clinical anaesthesiology, 2018

Related Questions

What is the proper method for maintaining sterile technique during the administration of local anesthetic?
What is the effective dose of local anesthesia, such as lidocaine (Lidocaine) or bupivacaine (Bupivacaine), for pain relief?
Can a proximal interphalangeal (PIP) joint dislocation reduction be done with local anesthesia, such as lidocaine or bupivacaine?
What are the guidelines for using bupivacaine as a local anesthetic in podiatric procedures?
What is the best anesthesia for simple suture wounds?
Should a patient with a history of Heart Failure with Reduced Ejection Fraction (HFrEF) due to hyperthyroidism, who has achieved euthyroidism and an ejection fraction (EF) of 64% after treatment with Gadolinium (Gd) contrast media, continue to use Gadolinium (Gd)?
Does the macula densa respond most closely to sodium or chloride concentration in the process of tubuloglomerular feedback?
Should a patient with heart failure with reduced ejection fraction (HFrEF) due to hyperthyroidism, who has achieved euthyroidism and an ejection fraction (EF) of 64% after treatment with the 4 pillars (Angiotensin-Converting Enzyme Inhibitors (ACEIs), Beta-Blockers (BB), Mineralocorticoid Receptor Antagonists (MRAs), and Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2is)), continue treatment with the 4 pillars?
What is the workup for elevated globulin (proteins) levels?
At what Glomerular Filtration Rate (GFR) do you refer a patient to a nephrologist?
At what Glomerular Filtration Rate (GFR) do you refer a patient to a nephrologist for dialysis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.